COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

BRInging the Diabetes Prevention Program to GEriatric Populations (BRIDGE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03524404
Recruitment Status : Completed
First Posted : May 14, 2018
Last Update Posted : November 29, 2019
Information provided by (Responsible Party):
NYU Langone Health

Brief Summary:
The purpose of this pilot study is to test the feasibility of implementing a telehealth adaption of the Diabetes Prevention Program (DPP) intervention among 30 NYC senior center members. The intervention will be conducted through 6 weekly webinars with a certified DPP coach. Participants will receive a binder and physical activity tracker to complete self-monitoring of diet and physical activity. The primary outcome is feasibility and acceptability of the intervention measured by workshop attendance and focus group feedback. Secondary outcomes include changes in diet, physical activity, and weight.

Condition or disease Intervention/treatment Phase
Diabetes Behavioral: 6 Week Intervention Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 16 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: BRInging the Diabetes Prevention Program to GEriatric Populations
Actual Study Start Date : March 28, 2018
Actual Primary Completion Date : April 15, 2019
Actual Study Completion Date : April 15, 2019

Arm Intervention/treatment
Active Comparator: Diabetes Prevention Program (DPP)
Live stream the first six sessions of the Diabetes Prevention Program (DPP) curriculum to Senior Planet on a weekly basis, The webinars will be about 1 hour long, led by a certified DPP educator, and live-streamed to the senior center. Participants will have weekly weigh-ins and meet with a research assistant led focus group following two out of the six sessions to discuss program acceptability.
Behavioral: 6 Week Intervention
Weekly interactive webinars based on the DPP curriculum at senior center.

Primary Outcome Measures :
  1. Program engagement [ Time Frame: 8 Weeks ]
    calculated by subtracting attending study visits from those enrolled

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   60 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Men and women age ≥ 60 years
  • Diabetes Risk Score >=5

Exclusion Criteria:

  • Decisional incapacity to consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03524404

Layout table for location information
United States, New York
New York University School of Medicine
New York, New York, United States, 10016
Sponsors and Collaborators
NYU Langone Health
Layout table for investigator information
Principal Investigator: Jeannette Beasley, MD
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: NYU Langone Health Identifier: NCT03524404    
Other Study ID Numbers: 18-00229
First Posted: May 14, 2018    Key Record Dates
Last Update Posted: November 29, 2019
Last Verified: November 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases